Janet Rush

Dr. Rush joined BTG in 2002.
Prior to joining BTG, she was Worldwide VP Cardiovascular Clinical Research at Aventis for eight years and spent many years at Merck (Executive Director US Clinical Development and Senior Director Cardiovascular Clinical Research).
In these positions she was responsible for worldwide approvals and market launches in US and Europe of five new drugs and 11 major efficacy supplements for new indications.
She obtained her medical degree from Ohio State University and medical residency from Boston University Hospital.
She is Board Certified in Internal Medicine and a Certified Physician Investigator.